Celanese partners with pharmaceutical company to release new glaucoma treatment


Glaukos' glaucoma treatment is set to address chronic side effects associated with skin medications by providing long-duration therapy.

Previous Dallas-based Dr. B Dental Solutions secures over $5M seed funding
Next Exelixis targeted for board challenge by Farallon Capital